4.7 Review

Relation between Vitamin D and COVID-19 in Aged People: A Systematic Review

期刊

NUTRIENTS
卷 13, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/nu13041339

关键词

vitamin D; COVID-19; aged people

向作者/读者索取更多资源

Vitamin D deficiency is associated with the risk of COVID-19 in elderly individuals, potentially leading to worse adverse outcomes. Supplementation of vitamin D appears to be an attractive option for preventive strategies against certain viral diseases.
Background: Vitamin D has diverse and extensive effects on the immune system, including activating innate immunity and reducing the overactive adaptive immune response. A systematic review was performed to identify and synthesize the best available evidence on the association between vitamin D level and risk of COVID-19, adverse outcomes and possible benefits of supplementation in aged 60 years or over. Methods: A literature search was performed in PubMed (c) and Scopus (c) for all publications from inception published before 15 March 2021. Studies reporting data from aged patients on vitamin D use and COVID-19 were included. Basic science articles, editorials and correspondence were excluded. Publication year, study design and setting, characteristics of the study population were extracted. This study is registered with PROSPERO, under the number CRD42020223993. Results: In total, 707 studies were identified, of which 11 observational studies were included in the final review. Four studies compared vitamin D-supplemented COVID-19 patients to non-supplemented patients, and seven compared patients with vitamin D deficiency to patients without deficiency. In all four studies, patients with vitamin D supplementation had better rates of primary clinical outcomes (death, the severity of the disease, oxygen therapy requirement horizontal ellipsis ). In studies comparing patients with vitamin D deficiency and patients without vitamin D deficiency, those without vitamin D deficiency had better primary clinical outcomes (death rate, the severity of the disease, oxygen therapy requirement, invasive mechanical ventilation need horizontal ellipsis ). Conclusion: This systematic review seems to support an association between vitamin D deficiency and the risk of COVID-19 in aged people. In addition, vitamin D deficiency appears to expose these subjects to a greater risk of adverse outcomes. Because of its simplicity of administration, and the rarity of side effects, including vitamin D in preventive strategies for certain viral diseases, it appears to be an attractive option.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy

Paul Dalla-Pozza, Maxime Hentzien, Clotilde Allavena, Anne Doe de Maindreville, Kevin Bouiller, Marc-Antoine Valantin, Emmanuel Lafont, Olivia Zaegel-Faucher, Antoine Cheret, Guillaume Martin-Blondel, Laurent Cotte, Firouze Bani-Sadr

Summary: This study highlights that factors other than low CD4(+) cell count and high HIV viral load may be associated with the occurrence of PML in people with HIV. Further studies are warranted to investigate in greater detail the immunologic characteristics of people with HIV who develop PML despite immune-virological control.
Article Infectious Diseases

Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting

Colin Deschanvres, Jacques Reynes, Isabelle Lamaury, David Rey, Romain Palich, Firouze Bani-Sadr, Olivier Robineau, Claudine Duvivier, Laurent Hocqueloux, Lise Cuzin, Veronique Joly, Francois Raffil, Andre Cabie, Clotilde Allavena

Summary: Maintenance ART with dolutegravir-based dual regimens has shown efficacy in HIV-1infected subjects, but real-life data are limited. In this study, virological failure and resistance-associated mutations were assessed in dolutegravir maintenance regimens. Results indicated that careful virological screening is essential before switching to dolutegravir maintenance regimens in virologically suppressed patients.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Infectious Diseases

Eosinophilia during Hantavirus infection: a cohort study

Messaline Bermejo, Stephanie Mestrallet, Amelie Servettaz, Laure-Anne Pannet, Delphine Lebrun, Yohan N'Guyen, Laurent Andreoletti, Jean-Marc Reynes, Maxime Hentzien, Firouze Bani-Sadr

Summary: The study found that about one quarter of patients with HFRS had eosinophilia, which was associated with severe thrombocytopenia, high C-reactive protein levels, white blood cell count, and neutrophil count, and inversely associated with nephrotoxic drug intake. Elevated C-reactive protein concentrations were independently associated with eosinophilia, supporting the role of eosinophils in antiviral immunity against hantavirus infection.

INFECTIOUS DISEASES (2022)

Review Oncology

Therapeutic Perspectives in the Systemic Treatment of Kaposi's Sarcoma

Marc-Antoine Valantin, Lena Royston, Maxime Hentzien, Aude Jary, Alain Makinson, Marianne Veyri, Sylvie Ronot-Bregigeon, Stephane Isnard, Romain Palich, Jean-Pierre Routy

Summary: Alternative systemic treatments are needed for patients with chemotherapy-refractory KS. Anti-angiogenic therapies and immune checkpoint blockade are potential therapeutic options to consider. In this review, potential therapeutic options for patients with recurrent or refractory KS are discussed, including systemic chemotherapies, immune checkpoint inhibitors, anti-herpesvirus agents, and anti-angiogenic drugs. Well-conducted clinical trials are urgently needed to evaluate the efficacy of targeted agents and immunomodulators in this patient population.

CANCERS (2022)

Editorial Material Infectious Diseases

Immunocompromised patients have been neglected in COVID-19 trials: a call for action

Marius Troseid, Maxime Hentzien, Florence Ader, Sandra Wagner Cardoso, Jose R. Arribas, Jean-Michel Molina, Nicolas Mueller, Maya Hites, Fabrice Bonnet, Oriol Manuel, Dominique Costagliola, Beatriz Grinsztejn, Inge Christoffer Olsen, Yazdan Yazdapanah, Alexandra Calmy

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Editorial Material Microbiology

Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants

Maxime Hentzien, Andrew Owen, Nathalie Strub-Wourgaft, Carmen Perez-Casas, Marius Troseid, Alexandra Calmy

FRONTIERS IN MICROBIOLOGY (2022)

Article Oncology

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

M. Dupont, Claire Carlier, C. Gower-Rousseau, P. Barbier-Lider, D. Botsen, M. Brasseur, A. Burgevin, C. Chourbagi, R. D'Almeida, V Hautefeuille, M. Hentzien, A. Lambert, M. Lamuraglia, S. Lavau-Denes, A. Lopez, D. Parent, F. Slimano, M. Brugel, O. Bouche

Summary: This study found that patients treated in the French area with the highest incidence of Lyme disease are at a higher risk of CI-IRs, suggesting the need for increased attention to the risk of CI-IRs in these patients in those regions.

BMC CANCER (2022)

Letter Immunology

Mycobacterium genavense mesenteritis responsible for refractory chylous ascites despite multiple immunomodulatory therapies in a patient with AIDS

Clemence Laurent, Maxime Hentzien, Simona Pavel, Kevin Didier, Messaline Bermejo, Yohan N'Guyen, Firouze Bani-Sadr

Article Immunology

Country of birth is associated with antiretroviral therapy choice in treatment-naive persons with HIV in France

Romain Palich, Maxime Hentzien, Laurent Hocqueloux, Claudine Duvivier, Clotilde Allavena, Thomas Huleux, Pierre Delobel, Alain Makinson, David Rey, Lise Cuzin

Summary: This study aimed to describe factors associated with the choice of first antiretroviral therapy (ART) in persons with HIV (PWH) in France, including the country of birth, as well as the time to undetectable viral load and treatment discontinuation. The results showed that, regardless of HIV disease parameters, PWH born abroad were less likely to choose integrase strand transfer inhibitors (INSTI) as a first-line therapy compared to those born in France. Therefore, qualitative data are needed to better understand physicians' prescribing practices.
Letter Biochemistry & Molecular Biology

The international Unity study for antivirals against mpox is a blueprint for future epidemics

Erica Telford, Beatriz Grinsztejn, Inge Christoffer Olsen, Nicolas Pulik, France Mentre, Skerdi Haviari, Maxime Hentzien, Olivier Segeral, Miquel B. Ekkelenkamp, Dimie Ogoina, Nathalie Strub-Wourgaft, Alpha Diallo, Yazdan Yazdanpanah, Alexandra Calmy

NATURE MEDICINE (2023)

Article Infectious Diseases

Early switching from intravenous to oral antibiotic therapy in bone and joint infections associated with methicillin-susceptible Staphylococcus aureus bacteremia

Maiwenn Petithomme-Nanrocki, Veronique Vernet-Garnier, Delphine Lebrun, Odile Bajolet, Morgane Bonnet, Maxime Hentzien, Xavier Ohl, Saidou Diallo, Firouze Bani-Sadr

Summary: This study evaluated the clinical outcomes of patients with bone and joint infection (BJI) associated with methicillin-susceptible Staphylococcus aureus bacteremia (MSSAB) treated with early oral switch to oral antibiotics (before day 14) versus later or no switch. The results showed that among 79 patients with BJI associated with MSSAB, 50.6% had an early switch to oral antibiotics, with a median duration of intravenous antibiotics of 9 days. The overall cure rate was 81% with a follow-up of 6 months, and failure to control BJI did not differ between the two groups.

INFECTIOUS DISEASES NOW (2023)

Meeting Abstract Immunology

Absence of viral rebound for 18 months without antiretrovirals after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells to treat a biphenotypic sarcoma

A. Saez-Cirion, A. -C. Mamez, V. Avettand-Fenoel, P. Thoueille, M. Nabergoj, M. Hentzien, E. Mereles Costa, M. Salgado, M. Nijhuis, A. Melard, E. Gardiennet, V. Monceaux, C. Passaes, A. Chapel, F. Perdomo-Celis, A. Wensing, J. Martinez-Picado, S. Yerly, M. Rougemont, A. Calmy

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Article Medical Laboratory Technology

Disappearance of anti-thyroglobulin antibodies from the cerebrospinal fluid in parallel with neurological improvement during treatment for Hashimoto's encephalopathy

Maiwen Petithomme-Nanrocki, Aurelie Brunet, Kevin Didier, Maxime Hentzien, Thierry Tabary, Anne Doe de Maindreville, Firouze Bani-Sadr

Summary: There is a relationship between the disappearance of antithyroid antibodies from the CSF and a decrease in serum thyroid antibodies in a patient with Hashimoto's encephalopathy, which correlates with favorable clinical outcome.

ANNALES DE BIOLOGIE CLINIQUE (2022)

Meeting Abstract Immunology

External validation of the Dat'AIDS score for predicting 5-year mortality among elderly people with HIV in the Swiss HIV Cohort Study

M. Hentzien, J. Frossard, R. Kouyos, V. Prendki, J. Damas, E. Hofmann, D. Braun, P. Schmid, E. Bernasconi, S. Ragozzino, O. Efthimiou, C. Delpierre, C. Allavena, F. Bani-Sadr, A. Calmy

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)

Article Medicine, General & Internal

Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort study

Sophie Demotier, Anne Limelette, Alexandre Charmillon, Elisabeth Baux, Xavier Parent, Stephanie Mestrallet, Simona Pavel, Amelie Servettaz, Moustapha Drame, Anaelle Muggeo, Alain Wynckel, Claire Gozalo, Malak Abou Taam, Aurelie Fillion, Roland Jaussaud, Thierry Trenque, Lionel Piroth, Firouze Bani-Sadr, Maxime Hentzien

Summary: This study found that approximately one-quarter of patients treated with high-dose intravenous amoxicillin developed amoxicillin crystalluria (AC), which was highly predictive of acute kidney injury (AKI). Factors associated with the occurrence of AC included the concomitant use of angiotensin converting enzyme inhibitors and a decrease in urinary pH.

ECLINICALMEDICINE (2022)

暂无数据